387 related articles for article (PubMed ID: 23651403)
1. Supercritical fluid particle design for poorly water-soluble drugs (review).
Sun Y
Curr Pharm Des; 2014; 20(3):349-68. PubMed ID: 23651403
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production.
Sheth P; Sandhu H; Singhal D; Malick W; Shah N; Kislalioglu MS
Curr Drug Deliv; 2012 May; 9(3):269-84. PubMed ID: 22283656
[TBL] [Abstract][Full Text] [Related]
4. Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs).
Kankala RK; Xu PY; Chen BQ; Wang SB; Chen AZ
Adv Drug Deliv Rev; 2021 Sep; 176():113846. PubMed ID: 34197896
[TBL] [Abstract][Full Text] [Related]
5. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
Yasuji T; Takeuchi H; Kawashima Y
Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
[TBL] [Abstract][Full Text] [Related]
6. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
Blagden N; de Matas M; Gavan PT; York P
Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
[TBL] [Abstract][Full Text] [Related]
7. Supercritical Fluid Particle Design of DPI Formulations (Review).
Sun Y
Curr Pharm Des; 2015; 21(19):2516-42. PubMed ID: 25876911
[TBL] [Abstract][Full Text] [Related]
8. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs.
Hu J; Johnston KP; Williams RO
Drug Dev Ind Pharm; 2004 Mar; 30(3):233-45. PubMed ID: 15109023
[TBL] [Abstract][Full Text] [Related]
10. APPLICATION OF VARIOUS POLYMERS AND POLYMERS BASED TECHNIQUES USED TO IMPROVE SOLUBILITY OF POORLY WATER SOLUBLE DRUGS: A REVIEW.
Muhammad Sarfraz R; Bashir S; Mahmood A; Ahsan H; Riaz H; Raza H; Rashid Z; Atif Raza S; Asad Abrar M; Abbas K; Yasmeen T
Acta Pol Pharm; 2017 Mar; 74(2):347-356. PubMed ID: 29624239
[TBL] [Abstract][Full Text] [Related]
11. Nanosuspensions of poorly water soluble drugs prepared by top-down technologies.
Zhang X; Li LC; Mao S
Curr Pharm Des; 2014; 20(3):388-407. PubMed ID: 23651400
[TBL] [Abstract][Full Text] [Related]
12. Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals - A comprehensive review.
Padrela L; Rodrigues MA; Duarte A; Dias AMA; Braga MEM; de Sousa HC
Adv Drug Deliv Rev; 2018 Jun; 131():22-78. PubMed ID: 30026127
[TBL] [Abstract][Full Text] [Related]
13. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
[TBL] [Abstract][Full Text] [Related]
14. Functionally engineered nanosized particles in pharmaceutics: improved oral delivery of poorly water-soluble drugs.
Ozeki T; Tagami T
Curr Pharm Des; 2013; 19(35):6259-69. PubMed ID: 23470003
[TBL] [Abstract][Full Text] [Related]
15. Solid dispersions: a review.
Dhirendra K; Lewis S; Udupa N; Atin K
Pak J Pharm Sci; 2009 Apr; 22(2):234-46. PubMed ID: 19339238
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs.
Kumar S; Gupta SK
Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):111-21. PubMed ID: 23331062
[TBL] [Abstract][Full Text] [Related]
17. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
Karwal R; Garg T; Rath G; Markandeywar TS
Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
[TBL] [Abstract][Full Text] [Related]
18. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
[TBL] [Abstract][Full Text] [Related]
19. Application of supercritical fluid technology for solid dispersion to enhance solubility and bioavailability of poorly water-soluble drugs.
Tran P; Park JS
Int J Pharm; 2021 Dec; 610():121247. PubMed ID: 34740762
[TBL] [Abstract][Full Text] [Related]
20. Tailoring Particle Microstructures via Supercritical CO₂ Processes for Particular Drug Delivery.
Liu G; Jiang Y; Wang X
Curr Pharm Des; 2015; 21(19):2543-62. PubMed ID: 25876917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
